Global Long Term Stability Testing Conditions: …
Global Long Term Stability Testing Conditions: Position of INDIA Saranjit Singh, Ph.D. National Institute of Pharmaceutical Education and Research (NIPER),
Download Global Long Term Stability Testing Conditions: …
Information
Domain:
Source:
Link to this page:
Documents from same domain
Role of packaging material on Pharmaceutical …
ipapharma.orgYOUR GLOBAL PARTENER IN SOLID DOSAGE SYSTEMS Role of packaging material on Pharmaceutical product stability Jnanadeva Bhat M. DGM - …
Effective Investigations and Corrective Actions(CAPA)
ipapharma.org© Copyright, Globepharm Consulting, 2008 11 21CFR820.100 - CAPA §820.100 Corrective and preventive action (a) Each manufacturer shall …
Good Pharmacy Practice Guidelines
ipapharma.org3 The Indian Pharmaceutical Association Good Pharmacy Practice Guidelines Documentation Committee Chairman Brijesh Regal Chairman, Community Pharmacy Division, (1998-2008)
Data Integrity 483’s / Warning Letters
ipapharma.org“483’s / Warning letters related to QC Data Integrity vis-a-vis Regulatory Expectations” Ranjit Barshikar Quality by Design / cGMP Consultant ranjitbarshikar@gmail.com ...
SCHEDULE M - ipapharma.org
ipapharma.org[SCHEDULE M] [See Rules 71, 74, 76 and 78] GOOD MANUFACTURING PRACTICES AND REQUIREMENTS OF PREMISES, PLANT AND EQUIPMENT FOR PHARMACEUTICAL PRODUCTS. Note: - To achieve the objectives listed below, each licensee shall evolve appropriate methodology, systems and procedures which shall be documented and maintained …
Related documents
COMMITTEE FOR MEDICINAL PRODUCTS FOR …
www.ema.europa.euRevision History . The guideline EMEA/CVMP/846/99 was revised to be brought in line with the requirements of the Note for Guidance on Stability Testing of New Veterinary Drug Substances and Medicinal Products
GUIDELINES FOR SUBMITTING APPLICATION FOR …
www.ich.org2 table of contents i. abbreviations ii. foreword iii. introduction iv. glossary 1. application form for registration and marketing of a medicine in the sadc region 1 2.
Registration of Medicines Stability - ICH Official …
www.ich.orgRegistration of Medicines Stability Stability v1.doc March 2004 1 SADC GUIDELINE FOR STABILITY TESTING 2004 This guideline is intended to provide requirements to applicants wishing to submit
MEDICINES CONTROL COUNCIL - mccza.com
www.mccza.comRegistration of Medicines Pharmaceutical & Analytical 2.02 PA Jun11 v6 showing changes.doc Page June 2011 1 of 27 MEDICINES CONTROL COUNCIL PHARMACEUTICAL AND ANALYTICAL
Guidelines on Drug Registration Applications in …
www.moh.gov.bwGUIDELINES ON DRUG REGISTRATION APPLICATIONS IN BOTSWANA Fourth Revised Edition JULY 2014 DRUGS ADVISORY BOARD C/O Drugs Regulatory Unit Floor 3 • Block D • Ministry of Health
ICH Topic Q 1 A Stability Testing Guidelines: …
www.pharma.gally.chThe European Agency for the Evaluation of Medicinal Products Human Medicines Evaluation Unit ICH - Technical Coordination - R. Bass 7 Westferry Circus, Canary Wharf, London E14 4HB, UK
STABILITY TESTING OF ACTIVE PHARMACEUTICAL …
www.who.intWorking document QAS/17.694 page 3 Introduction and background36 37 38 The Stability testing of active pharmaceutical ingredients and finished 39 pharmaceutical products was published as Annex 2 in the WHO Technical 40 Report Series, No. 953, 2009 (1). 41 42 These regulatory guidelines seek to exemplify the core stability data package 43 required for registration …
STABILITY TESTING OF ACTIVE SUBSTANCES AND …
www.who.intWorking document QAS/06.179 page 2 REGIONAL GUIDELINE FOR THE WHO EASTERN MEDITERRANEAN REGION STABILITY TESTING OF ACTIVE SUBSTANCES AND PHARMACEUTICAL PRODUCTS DRAFT 2.0 19 April 2006 This guideline has been developed during the WHO EMRO Consultation on Regional
Related search queries
Stability, FOR SUBMITTING APPLICATION FOR, Registration, Registration of Medicines Stability, Registration of Medicines Stability Stability, MEDICINES CONTROL COUNCIL, Registration of Medicines, A Stability Testing Guidelines:, Medicines, PHARMACEUTICAL, Pharmaceutical ingredients and, STABILITY TESTING OF ACTIVE SUBSTANCES, STABILITY TESTING OF ACTIVE SUBSTANCES AND PHARMACEUTICAL PRODUCTS